Search

Displaying results 5121 - 5130 of 10000 in total
  1. Drug

    Adrixetinib

    go.drugbank.com/drugs/DB21620
    Investigational

    Adrixetinib has a monoisotopic molecular weight of 531.17 Da. … Adrixetinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Adrixetinib is a tyrosine kinase inhibitor.

  2. Drug

    Friluglanstat

    go.drugbank.com/drugs/DB21652
    Experimental

    Friluglanstat has a monoisotopic molecular weight of 516.12 Da. … Friluglanstat is a small molecule drug. The usage of the INN stem '-glanstat' in the name indicates that Friluglanstat is a prostaglandin synthase inhibitor.

  3. Drug

    Canlitinib

    go.drugbank.com/drugs/DB21656
    Experimental

    Canlitinib has a monoisotopic molecular weight of 619.21 Da. … Canlitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Canlitinib is a tyrosine kinase inhibitor.

  4. Drug

    Labuxtinib

    go.drugbank.com/drugs/DB21658
    Experimental

    Labuxtinib has a monoisotopic molecular weight of 377.13 Da. … Labuxtinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Labuxtinib is a tyrosine kinase inhibitor.

  5. Drug

    Talorasib

    go.drugbank.com/drugs/DB21686
    Experimental

    Talorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Talorasib is a Ras protein inhibitor. Talorasib has a monoisotopic molecular weight of 604.24 Da.

  6. Drug

    Nadofaragene firadenovec

    go.drugbank.com/drugs/DB17381
    ApprovedInvestigational

    Nadofaragene firadenovec (nadofaragene firadenovec-vncg) is a recombinant non-replicating adenovirus serotype 5 vector containing a transgene encoding human interferon alfa-2b (IFNα2b). … [A255106,L44381] Nadofaragene firadenovec also has a manageable adverse event profile. Compared to [pembrolizumab], a smaller proportion of patients experienced grade 3-4 adverse events (4% vs 12.7%).

  7. Drug

    Axicabtagene ciloleucel

    go.drugbank.com/drugs/DB13915
    ApprovedInvestigational

    The drug has a unique mechanism of action, as it utilizes the patient's own T cells, which play a central role in immune response to cancer. … [L40054] The development of resulted from early preclinical studies conducted by a group of researchers at the National Cancer Institute (NCI), who demonstrated that T cells expressing an anti-CD19 CAR

    Synonyms: Autologous T cells transduced with retroviral vector encoding an anti-CD-19 CD28/CD3-zeta chimeric antigen receptor
  8. Drug

    Epertinib

    go.drugbank.com/drugs/DB20062
    Experimental

    Epertinib has a monoisotopic molecular weight of 559.18 Da. … Epertinib is a small molecule drug. The usage of the INN stem '-ertinib' in the name indicates that Epertinib is a epidermal growth factor receptor (EGFR) inhibitor.

  9. Drug

    Quiflapon

    go.drugbank.com/drugs/DB20376
    Experimental

    Quiflapon has a monoisotopic molecular weight of 586.21 Da. … Quiflapon is a small molecule drug. The usage of the INN stem '-flapon' in the name indicates that Quiflapon is a 5-lipoxygenase-activating protein (FLAP) inhibitor.

  10. Drug

    Burapitant

    go.drugbank.com/drugs/DB20607
    Experimental

    Burapitant has a monoisotopic molecular weight of 681.2 Da. … Burapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Burapitant is a neurokinin NK1​ (substance P) receptor antagonist.